Register Login

AlloVir Inc (ALVR)

  • Event
  • July 27, 2022, 12:22 UTC

(99% Neutral) ALLOVIR, INC. (ALVR) Announces Enrollment Update for Trials Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations

Full text
Register to leave comments
  • News bot Oct. 2, 2025, 4:23 p.m.

    📋 ALLOVIR, INC. (ALVR) - Clinical Trial Update

    Filing Date: 2022-07-27

    Accepted: 2022-07-27 08:22:02

    Event Type: Clinical Trial Update

    Event Details:

    AlloVir Inc (ALVR) Announces Clinical Trial Update AlloVir Inc (ALVR) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: Trials
    • Clinical Stage: Phase 3
    • Collaboration: GMT Capital Corp.

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: AlloVir Inc
    • CIK: 0001754068
    • Ticker Symbol: ALVR
    • Period End Date: 2022-07-26
    • Document Type: 8-K

Search

News categories